You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Imatinib and/or Bosutinib Intolerance

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Condition Vasoregulation Function Endothelium in CML Getting TKI

Recruiting
  • Chronic Myeloid Leukaemia
  • taking blood for the study of biochemical parameters and the study of microcirculation using the method of laser Doppler flowmetry
  • Moscow, Russian Federation
  • +1 more
Jan 11, 2023

Gastric Echography for Early Diagnosis of Nutritional

Recruiting
  • Nutritional Intolerance
  • 2 Blood samples from arterial and/or central venous catheters
  • +2 more
  • Dijon, France
    Chu Dijon Bourogne
Dec 7, 2021

Gastrointestinal Stromal Tumors Trial in Seoul (PDR001, Imatinib)

Recruiting
  • Gastrointestinal Stromal Tumors
  • PDR001, Imatinib
  • Seoul, Korea, Republic of
    Asan Medical Center
Jun 22, 2021

Glucose Intolerance, Obesity Trial in Basel (Low Carb diet)

Recruiting
  • Glucose Intolerance
  • Obesity
  • Low Carb diet
  • Basel, Switzerland
    St Clara Research Ltd, St Claraspital Basel
Oct 4, 2021

Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive Trial in Worldwide

Completed
Has Results
  • Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive
  • Anaheim, California
  • +188 more
Apr 16, 2021

Chronic Myelogenous Leukemia Trial in Worldwide (Asciminib, Bosutinib)

Active, not recruiting
Has Results
  • Chronic Myelogenous Leukemia
  • Chicago, Illinois
  • +87 more
Jan 20, 2023

Orthostatic Intolerance and Hypotension After Administration of

Recruiting
  • Orthostatic Hypotension
  • Orthostatic Intolerance
  • Hvidovre, Denmark
    Hvidovre University Hospital
Jun 15, 2021

Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders, Diabetes Trial (Educational intervention)

Not yet recruiting
  • Schizophrenia
  • +6 more
  • Educational intervention
  • (no location specified)
Jul 10, 2023

Rheumatoid Arthritis Trial in Beijing (TLL-018, Tofacitinib)

Recruiting
  • Rheumatoid Arthritis
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Apr 7, 2022

Diabetes, PreDiabetes, Food Insecurity Trial in Bronx (Fresh Takes!)

Not yet recruiting
  • Diabetes
  • +2 more
  • Fresh Takes!
  • Bronx, New York
    Montefiore Bronx Health Collective
Aug 31, 2023

Rheumatoid Arthritis (RA) Trial in China, Korea, Republic of, Taiwan (Peficitinib, Plaebo, Disease-modifying antirheumatic drugs

Completed
  • Rheumatoid Arthritis (RA)
  • Anhui, China
  • +42 more
Jan 7, 2023

Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Frankfurt (Main) (Rituximab, Nelarabine, PEG-Asparaginase)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Lymphoblastic Lymphoma
  • Frankfurt (Main), Germany
    University Hospital of Frankfurt (Main)
Jul 1, 2022

Flumatinib Versus Nilotinib for Chronic Phase Chronic Myeloid

Recruiting
  • CML-CP; Mutation;Suboptimal Response or Failure in TKI
  • Wuhan, Hubei, China
    Weiming Li
May 31, 2021

Accelerated Phase Chronic Myelogenous Leukemia (CML), Blast Phase Chronic Myelogenous Leukemia (CML), Chronic Phase Phase

Terminated
  • Accelerated Phase Chronic Myelogenous Leukemia (CML)
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 17, 2020

PreDiabetes, Impaired Glucose Tolerance Trial in Sha Tin (High FODMAP diet with metformin, Low FODMAP diet with metformin)

Not yet recruiting
  • PreDiabetes
  • Impaired Glucose Tolerance
  • High FODMAP diet with metformin
  • Low FODMAP diet with metformin
  • Sha Tin, Hong Kong
    Prince of Wales Hospital
Nov 16, 2022

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in United States (Bosutinib, Dasatinib, Laboratory Biomarker

Active, not recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Anchorage, Alaska
  • +540 more
Dec 14, 2022

Chronic Myelogenous Leukemia, Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia Trial in Worldwide (ABL001, ABL001 +

Active, not recruiting
  • Chronic Myelogenous Leukemia
  • Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
  • Boston, Massachusetts
  • +18 more
Jan 19, 2023

Gastro Intestinal Stromal Tumour Trial in France (Lenvatinib, Placebo, Best supportive care)

Recruiting
  • Gastro Intestinal Stromal Tumour
  • Marseille, Bouches Du Rhône, France
  • +7 more
Jul 28, 2021

Unresectable Gastrointestinal Stromal Tumor (GIST), Locally Advanced Gastrointestinal Stromal Tumor (GIST), Metastatic

Recruiting
  • Unresectable Gastrointestinal Stromal Tumor (GIST)
  • +2 more
  • Atezolizumab 1200 mg
  • Imatinib 400 MG
  • Lyon, Rhône, France
  • +4 more
Apr 28, 2022

Previously Treated PH + CML Trial in Worldwide (Bosutinib)

Terminated
Has Results
  • Previously Treated PH + CML
  • Los Angeles, California
  • +47 more
Dec 2, 2021

Familial Mediterranean Fever, FMF Trial in Yerevan, Tbilisi, Saint Petersburg (RPH-104, Placebo)

Recruiting
  • Familial Mediterranean Fever
  • FMF
  • RPH-104
  • Placebo
  • Yerevan, Armenia
  • +4 more
Oct 12, 2021

The Life After Stopping Tyrosine Kinase Inhibitors Study

Completed
  • Leukemia, Myeloid, Chronic
  • Imatinib (Stopping their TKI)
  • +3 more
  • San Francisco, California
  • +15 more
Jan 3, 2023

Metastatic Pancreatic Adenocarcinoma Trial in France (Gemcitabine, Paclitaxel)

Completed
  • Metastatic Pancreatic Adenocarcinoma
  • Bayeux, France
  • +25 more
May 17, 2022

Diabetes, Type 2, Overweight and Obesity, PreDiabetes Trial in Zaragoza (Low-calorie and high-protein diet with the majority of

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • +2 more
  • Low-calorie and high-protein diet with the majority of protein coming from animal sources.
  • Low-calorie and high-protein diet with the majority of protein coming from plant sources.
  • Zaragoza, Spain
    Instituto de Investigación Sanitaria Aragón, Hospital Universita
Jul 8, 2022

Rheumatoid Arthritis Trial (ABT-494, Placebo)

Completed
Has Results
  • Rheumatoid Arthritis
  • (no location specified)
Jul 29, 2021